3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties.
about
Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingNanoparticles in magnetic resonance imaging: from simple to dual contrast agentsGadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes.Gd Complexes of DO3A-(Biphenyl-2,2'-bisamides) Conjugates as MRI Blood-Pool Contrast Agents.Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiographyHigh-contrast in vivo visualization of microvessels using novel FeCo/GC magnetic nanocrystals.Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.Macromolecular and dendrimer-based magnetic resonance contrast agents.PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approachMR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticlePreparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.Biologically optimized nanosized molecules and particles: more than just size.Synthesis of a novel polyamidoamine dendrimer conjugating with alkali blue as a lymphatic tracer and study on the lymphatic targeting in vivo.Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiographyPreparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging.Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agentsGadolinium-based contrast agents for magnetic resonance cancer imaging.Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.Three-dimensional reconstruction of blood vessels in the rabbit eye by X-ray phase contrast imaging.Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging.Tumour and dendrimers: a review on drug delivery aspects.Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents.Effects of nanomaterial physicochemical properties on in vivo toxicity.High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Dendrimers as high relaxivity MR contrast agents.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Recent advances in targeted drug delivery approaches using dendritic polymers.Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.Polymeric therapeutic delivery systems for the treatment of infectious diseases.
P2860
Q26785347-CE08EFBE-1825-4D94-9568-51B5663A31D8Q28082690-FE4F2881-6569-4510-9328-C160D7E67068Q30571992-54D83E1C-C7A2-4B20-94C4-31960A8FEA7FQ30820441-08489D45-99CA-4C0F-9092-F0D3E92A9B01Q30829168-31A87790-2ADD-40C1-A212-CB1CE65812A0Q33570993-D1CF8EA0-935F-41F3-83FA-22AEFC699EBFQ33668678-B8CC5605-AE5A-4EE2-91F4-51A379E396FAQ34023045-1DD675D9-CF76-4C72-8DE4-6A1A4D593961Q34069230-CB5D2751-C5F3-4390-A278-3EE43E675B32Q34165944-63DE702F-0192-48A8-8F3B-06FD5879D884Q34204259-D7157C46-DF09-4971-8667-BA8AE7DEEAF8Q34736942-6B3F5371-11D4-4470-889F-59F8CEC58D01Q34769916-94E6E7FB-B51C-44B1-BA97-697A22E3579CQ34850437-D32D9493-9BEE-480B-A864-3B2AA6DE6A95Q34916107-38D2F405-B891-4CA1-BC8A-C34030BDE5A9Q35048175-A52A8C53-D5D4-4A7D-85CC-96114CDE645FQ35433287-3AD0755E-204F-45F3-B99A-1325E9EE4DF1Q35605967-D8B1C878-C344-4AF4-8B40-611D43216E42Q35786690-C7A98FD3-73FD-40C7-8D4E-A30AB5AB277CQ35851983-3A1D9D9A-C888-44EB-A9A7-28A8950440BCQ36125194-36DC71D2-E76E-4CFC-BB26-910B71CA9476Q36216849-8BD12E73-82A7-4797-874C-C6173DCFFE24Q36516259-437A7651-D02D-4331-A3BA-144E98F75267Q36555415-9BAD75B5-22AB-4297-A9FE-5C369A0B9E4FQ36759502-D01571B5-393A-4197-8F97-A4ADB85F9FC2Q36811707-AFE2D981-BEF9-4DF6-923C-E41E0476C1CBQ36920307-9BC92723-12C0-4A7B-9629-19B35EAB7312Q36952077-7C286B24-1C83-420D-AFC5-212797119F63Q37010649-1205FF08-3C35-4559-9A2F-09F586F2CB1AQ37171165-ADA05EEA-C285-44E5-B0EE-25B0DF4A1D5FQ37272933-33B5B0A2-DBF2-485C-9147-5DF018F616ECQ37345372-258415F7-CE26-4CF3-8E1B-0F2F57CAE29EQ37456409-7BE49629-72DC-40C6-BA50-5BA64BC3AD60Q37823446-43ACF259-CF59-4A8E-80E7-CFA933C26410Q37939967-3A91DA85-C6F6-4E3D-B277-2DF8C3A88145Q38155137-48D22D1C-CE39-4440-9FE0-65B5CF83979BQ38155457-7B2D0CD3-1A06-428E-B429-7AD5ED756DF7Q38556761-DE4B1C3B-2609-476F-BD3E-D581E42F2E6EQ39332969-C6787CFE-89B2-4EDB-8985-76759957773AQ39386505-0035B37A-E1DB-4190-9AD9-60F117B19C33
P2860
3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@ast
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@en
type
label
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@ast
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@en
prefLabel
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@ast
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@en
P2093
P2860
P1476
3D-micro-MR angiography of mic ...... ir pharmacokinetic properties.
@en
P2093
H Kobayashi
M W Brechbiel
Y Nakamoto
P2860
P304
P356
10.1002/1522-2594(200103)45:3<454::AID-MRM1060>3.0.CO;2-M
P577
2001-03-01T00:00:00Z